Larimar Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Larimar Therapeutics

13/05/2024 14:30

* Larimar Therapeutics Inc  LRMR.OQ  reported a quarterly
adjusted
loss of 27 cents​​ per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of -15 cents.  The mean expectation of five analysts for the
quarter was for a loss of 23 cents per share. Wall Street
expected results to range from -25 cents to -21 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Larimar Therapeutics Inc's reported EPS for the quarter
was a
loss of 27 cents​.
    * The company reported a quarterly loss of $14.65 million.
    * Larimar Therapeutics Inc shares had fallen by 6.2% this
quarter and gained 56.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 15.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Larimar
Therapeutics Inc is $25.00 
This summary was machine generated from LSEG data May 13 at
01:30 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.23          -0.27          Missed
 Dec. 31 2023      -0.25          -0.30          Missed
 Sep. 30 2023      -0.22          -0.21          Beat
 Jun. 30 2023      -0.19          -0.19          Met